The first case of cavitary pulmonary disease caused by Purpureocillium lilacinum is described. The isolate showed atypical microscopic characteristics similar to Acremonium and Fusarium spp., which necessitated molecular identification by sequencing of multiple conserved loci. The patient responded to voriconazole, reinforcing its therapeutic efficacy for P. lilacinum infections.
CASE REPORTA n 80-year-old asthmatic woman presented with a 3-week history of productive cough, associated with fever and pleuritic chest pain, which did not respond to a week of treatment with antibiotics and steroid therapy. She had a history of asthma, coronary artery disease, diabetes mellitus, hypertension, dyslipidemia, rheumatoid arthritis, and osteoporosis. Clinically, she presented with fever, tachypnea, tachycardia, and hypotension. Chest auscultation revealed bilateral scattered wheezes. The rest of the physical findings were unremarkable. Within 24 h of admission, her condition progressively deteriorated, requiring mechanical ventilation. As the patient was febrile, she was empirically started on ceftriaxone and clarithromycin. Her initial assessment revealed a normal white cell count, but the chest X-ray showed a consolidative lesion in the left upper lobe (LUL). The sputum culture showed heavy growth of Pseudomonas aeruginosa. Consequently, her antibiotic regimen was modified to include ciprofloxacin and meropenem for a course of 14 days, followed by a 3-week course of tazocin-ciprofloxacin. Despite an initial clinical improvement, the follow-up chest X ray showed persistence of the LUL lesion. Therefore, a computed tomography (CT) scan of the chest was performed on 7 October 2010, which revealed a cavitary lesion in the anterior segment of the LUL (Fig. 1A).Since her condition deteriorated further, as assessed by her oxygen requirements, sputum specimens were collected on 11 and 18 October 2010 and were sent to the Mycology Reference Laboratory (MRL), Faculty of Medicine, Kuwait University. Both specimens showed septate hyphal elements when examined with calcofluor-potassium hydroxide (Fig. 2) and grew a white mold after 5 days on Sabouraud dextrose agar (Difco, Becton, Dickinson and Company, Sparks, MD). On 21 October 2010, a bronchoalveolar lavage (BAL) specimen from the LUL was obtained and sent to the MRL to establish the role of this white mold in the etiology of her cavitary lung lesion. The BAL specimen also showed septate fungal elements in the calcofluor-KOH mount (Fig. 2) and yielded a morphologically identical mold culture. The mold was provisionally identified as Acremonium or Paecilomyces. Although no defined antifungal susceptibility breakpoints exist for these organisms, the isolate demonstrated high MICs to amphotericin B (Ն32 g/ml), caspofungin (4 g/ml), and itraconazole (Ն32 g/ml), suggesting resistance, but low MICs for posaconazole (0.5 g/ml) and voriconazole (0.064 g/ml), suggesting clinical efficacy. The patient was thus started on voriconazole, at 6 mg/kg of body weight at 12-h intervals for the fir...